Semnur Pharmaceuticals Overview
- Year Founded
-
2013
- Status
-
Public
- Stock Symbol
-
SMNR
- Investments
-
1
Semnur Pharmaceuticals General Information
Description
Developer of non-opioid pain therapies designed for the treatment of chronic radicular pain and sciatica. The company's lead product is a novel injectable corticosteroid gel formulation administered epidurally without preservatives or particulates, enabling healthcare providers to offer sciatica patients targeted pain relief and improved disability scores through a specialized non-opioid treatment option.
Contact Information
Website
www.semnurpharma.comCorporate Office
- 960 San Antonio Road
- Palo Alto, CA 94303
- United States
Corporate Office
- 960 San Antonio Road
- Palo Alto, CA 94303
- United States
Semnur Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Semnur Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Semnur Pharmaceuticals Comparisons
Industry
Financing
Details
Semnur Pharmaceuticals Competitors (30)
One of Semnur Pharmaceuticals’s 30 competitors is Pacira BioSciences, a Formerly VC-backed company based in Tampa, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pacira BioSciences | Formerly VC-backed | Tampa, FL | ||||
| Sollis Therapeutics | Venture Capital-Backed | Hilliard, OH | ||||
| Phoenix PharmaLabs | Venture Capital-Backed | Salt Lake City, UT | ||||
| Bridge Therapeutics | Venture Capital-Backed | Birmingham, AL | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria |
Semnur Pharmaceuticals Patents
Semnur Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2974657-A1 | Injectable pharmaceutical composition comprising dexamethasone sodium phosphate | Active | 21-Jan-2015 | ||
| CA-2974657-C | Injectable pharmaceutical composition comprising dexamethasone sodium phosphate | Active | 21-Jan-2015 | ||
| EP-3247329-B1 | Injectable pharmaceutical composition comprising dexamethasone sodium phosphate | Active | 21-Jan-2015 | ||
| EP-3247329-B3 | Injectable pharmaceutical composition comprising dexamethasone sodium phosphate | Active | 21-Jan-2015 | ||
| EP-3925597-A1 | Injectable pharmaceutical composition comprising dexamethasone sodium phosphate | Active | 21-Jan-2015 | A61K47/36 |
Semnur Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Semnur Pharmaceuticals Acquisitions (1)
Semnur Pharmaceuticals’s most recent deal was a Merger/Acquisition with Denali Capital Acquisition. The deal was made on 22-Sep-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Denali Capital Acquisition | 22-Sep-2025 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Semnur Pharmaceuticals FAQs
-
When was Semnur Pharmaceuticals founded?
Semnur Pharmaceuticals was founded in 2013.
-
Where is Semnur Pharmaceuticals headquartered?
Semnur Pharmaceuticals is headquartered in Palo Alto, CA.
-
What industry is Semnur Pharmaceuticals in?
Semnur Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Semnur Pharmaceuticals a private or public company?
Semnur Pharmaceuticals is a Public company.
-
What is Semnur Pharmaceuticals’s stock symbol?
The ticker symbol for Semnur Pharmaceuticals is SMNR.
-
Who are Semnur Pharmaceuticals’s competitors?
Pacira BioSciences, Sollis Therapeutics, Phoenix PharmaLabs, Bridge Therapeutics, and Pfizer (Vienna) are some of the 30 competitors of Semnur Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process